Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer discussed, along with the tech battleground. Answering a caller’s query about the stock during the lightning round, Cramer ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

H&R Block's e-filing products are intuitive and easy to use. For paid users, tax pro support is available via screen share or chat. Many, or all, of the products featured on this page are from our ...

Carla Tardi is a technical editor and digital content producer with 25+ years of experience at top-tier investment banks and money-management firms. Erika Rasure is globally-recognized as a leading ...

Sign up to receive the TV WEEK e-Newsletter and offers we choose to share with you straight to your inbox On Friday, Mat took to Instagram to reveal that his friend ...

Blockchain is the core technology behind Bitcoin and thousands of cryptocurrencies and has promising potential beyond digital currencies. Many, or all, of the products featured on this page are from ...